{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360004232298398208.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.jneuroim.2011.08.016"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0165572811002335?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0165572811002335?httpAccept=text/plain"}},{"identifier":{"@type":"PMID","@value":"21914557"}}],"resourceType":"学術雑誌論文(journal article)","dc:title":[{"@value":"Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain–Barré syndrome and chronic inflammatory demyelinating polyneuropathy"}],"description":[{"notation":[{"@value":"LM1 is localized in human peripheral nerve myelin. Antibodies to ganglioside complexes (GSCs) have been reported in Guillain-Barré syndrome (GBS). We investigated IgG antibodies to LM1 and two GSCs (GM1 and LMI, or GD1b and LM1) in the sera of each 40 patients with chronic inflammatory demyelinating polyneuropathy (CIDP) and GBS, using ELISA. We detected anti-LM1 antibody in five with GBS and seven with CIDP; anti-GM1/LM1 antibody in three with GBS and one with CIDP; and anti-GD1b/LM1 antibody in two with CIDP. Antibodies to LM1 and LM1-containing GSCs may be among the targets for autoimmunity in GBS and CIDP."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380004232298398211","@type":"Researcher","foaf:name":[{"@value":"Motoi Kuwahara"}]},{"@id":"https://cir.nii.ac.jp/crid/1380004232298398209","@type":"Researcher","foaf:name":[{"@value":"Seiko Suzuki"}]},{"@id":"https://cir.nii.ac.jp/crid/1030566608563590401","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"50330262"},{"@type":"NRID","@value":"1000050330262"},{"@type":"NRID","@value":"9000002289111"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/read0058351"}],"foaf:name":[{"@value":"Kazuo Takada"}]},{"@id":"https://cir.nii.ac.jp/crid/1420845751166931072","@type":"Researcher","personIdentifier":[{"@type":"KAKEN_RESEARCHERS","@value":"90195438"},{"@type":"NRID","@value":"1000090195438"},{"@type":"CINII_AUTHOR_ID","@value":"DA10083762"},{"@type":"URI","@value":"https://ci.nii.ac.jp/author/DA10083762#entity"},{"@type":"URI","@value":"https://viaf.org/viaf/NII%7CDA10083762"},{"@type":"NRID","@value":"9000001032235"},{"@type":"NRID","@value":"9000297483894"},{"@type":"NRID","@value":"9000258061098"},{"@type":"NRID","@value":"9000322104913"},{"@type":"NRID","@value":"9000345404429"},{"@type":"NRID","@value":"9000399801293"},{"@type":"NRID","@value":"9000019147277"},{"@type":"NRID","@value":"9000402138919"},{"@type":"NRID","@value":"9000414845881"},{"@type":"NRID","@value":"9000402374363"},{"@type":"NRID","@value":"9000311058435"},{"@type":"NRID","@value":"9000403309556"},{"@type":"NRID","@value":"9000001436103"},{"@type":"NRID","@value":"9000413510918"},{"@type":"NRID","@value":"9000017720699"},{"@type":"NRID","@value":"9000403282946"},{"@type":"NRID","@value":"9000404827028"},{"@type":"NRID","@value":"9000022058580"},{"@type":"NRID","@value":"9000298898194"},{"@type":"NRID","@value":"9000405896015"},{"@type":"NRID","@value":"9000410317782"},{"@type":"NRID","@value":"9000258058191"},{"@type":"NRID","@value":"9000413391889"},{"@type":"NRID","@value":"9000379555664"},{"@type":"NRID","@value":"9000002152668"},{"@type":"NRID","@value":"9000258058432"},{"@type":"NRID","@value":"9000107387228"},{"@type":"NRID","@value":"9000408889560"},{"@type":"NRID","@value":"9000258060422"},{"@type":"NRID","@value":"9000258058105"},{"@type":"NRID","@value":"9000242713501"},{"@type":"NRID","@value":"9000342444869"},{"@type":"NRID","@value":"9000010915757"},{"@type":"NRID","@value":"9000022062332"},{"@type":"NRID","@value":"9000347228265"},{"@type":"NRID","@value":"9000345282547"},{"@type":"NRID","@value":"9000402374351"},{"@type":"NRID","@value":"9000022129024"},{"@type":"NRID","@value":"9000252877397"},{"@type":"NRID","@value":"9000391987448"},{"@type":"NRID","@value":"9000370745186"},{"@type":"NRID","@value":"9000403274319"},{"@type":"NRID","@value":"9000409862016"},{"@type":"NRID","@value":"9000391550908"},{"@type":"NRID","@value":"9000007158231"},{"@type":"NRID","@value":"9000242155767"},{"@type":"NRID","@value":"9000410747916"},{"@type":"NRID","@value":"9000018868672"},{"@type":"NRID","@value":"9000345289808"},{"@type":"NRID","@value":"9000240056049"},{"@type":"NRID","@value":"9000345382336"},{"@type":"NRID","@value":"9000409864113"},{"@type":"NRID","@value":"9000258060545"},{"@type":"NRID","@value":"9000000565872"},{"@type":"NRID","@value":"9000260215247"},{"@type":"NRID","@value":"9000022069449"},{"@type":"NRID","@value":"9000387366393"},{"@type":"NRID","@value":"9000408423794"},{"@type":"NRID","@value":"9000398275456"},{"@type":"NRID","@value":"9000283226064"},{"@type":"NRID","@value":"9000258058290"},{"@type":"NRID","@value":"9000369357738"},{"@type":"NRID","@value":"9000361704055"},{"@type":"NRID","@value":"9000304615765"},{"@type":"NRID","@value":"9000283542360"},{"@type":"NRID","@value":"9000338431206"},{"@type":"RESEARCHMAP","@value":"https://researchmap.jp/read0110817"}],"foaf:name":[{"@value":"Susumu Kusunoki"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"01655728"}],"prism:publicationName":[{"@value":"Journal of Neuroimmunology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2011-10","prism:volume":"239","prism:number":"1-2","prism:startingPage":"87","prism:endingPage":"90"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0165572811002335?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0165572811002335?httpAccept=text/plain"}],"createdAt":"2011-09-13","modifiedAt":"2025-09-28","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=Enzyme-Linked%20Immunosorbent%20Assay","dc:title":"Enzyme-Linked Immunosorbent Assay"},{"@id":"https://cir.nii.ac.jp/all?q=Guillain-Barre%20Syndrome","dc:title":"Guillain-Barre Syndrome"},{"@id":"https://cir.nii.ac.jp/all?q=Protein%20Transport","dc:title":"Protein Transport"},{"@id":"https://cir.nii.ac.jp/all?q=Polyradiculoneuropathy,%20Chronic%20Inflammatory%20Demyelinating","dc:title":"Polyradiculoneuropathy, Chronic Inflammatory Demyelinating"},{"@id":"https://cir.nii.ac.jp/all?q=Gangliosides","dc:title":"Gangliosides"},{"@id":"https://cir.nii.ac.jp/all?q=Immunoglobulin%20G","dc:title":"Immunoglobulin G"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Myelin%20Sheath","dc:title":"Myelin Sheath"},{"@id":"https://cir.nii.ac.jp/all?q=Autoantibodies","dc:title":"Autoantibodies"}],"project":[{"@id":"https://cir.nii.ac.jp/crid/1040000782073447040","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"21390273"},{"@type":"JGN","@value":"JP21390273"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21390273/"}],"notation":[{"@language":"ja","@value":"抗ガングリオシド抗体による神経細胞障害機序の解析:細胞内シグナル伝達への作用"},{"@language":"en","@value":"Analysis of the neuropathogenic mechanisms induced by the antiganglioside antibodies : the effect on signal transduction in neurons"}]},{"@id":"https://cir.nii.ac.jp/crid/1040000782145522560","@type":"Project","projectIdentifier":[{"@type":"KAKEN","@value":"23249048"},{"@type":"JGN","@value":"JP23249048"},{"@type":"URI","@value":"https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-23249048/"}],"notation":[{"@language":"ja","@value":"網羅的自己抗体プロファイリング法に基づく免疫性神経疾患の病態解明と治療戦略の構築"},{"@language":"en","@value":"Elucidation of molecular basis and therapeutic strategy of immune-mediated neurological diseases based on comprehensive analysis of autoantibodies"}]}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050001202611065728","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Development of new ganglioside probes and unraveling of raft domain structure by single-molecule imaging"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002216027827072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Serological study using glycoarray for detecting antibodies to glycolipids and glycolipid complexes in immune-mediated neuropathies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011146593961728","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Myelin Gangliosides of Human Peripheral Nervous System: An Enrichment of GM1 in the Motor Nerve Myelin Isolated from Cauda Equina"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617805443584","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A Guillain-Barré syndrome-associated SIGLEC10 rare variant impairs its recognition of gangliosides"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619317616128","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Anti-ganglioside complex antibodies associated with severe disability in GBS"}]},{"@id":"https://cir.nii.ac.jp/crid/1360292619502118400","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Glycosphingolipid composition of primary cultured human brain microvascular endothelial cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567185446788992","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Mechanism and spectrum of anti‐glycolipid antibody‐mediated chronic inflammatory demyelinating polyneuropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360568466998604160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Complement deposition and macrophage-induced demyelination in CIDP with anti-LM1 antibodies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574096412615936","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657228490624","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Antibodies to ganglioside complexes consisting of asialo-GM1 and GQ1b or GT1a in Fisher and Guillain–Barré syndromes"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657228643200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Autoantibodies against vinculin in patients with chronic inflammatory demyelinating polyneuropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567482734080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Antiglycolipid antibodies in Guillain-Barré and Fisher syndromes: discovery, current status and future perspective"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567579619072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Efficacy and Safety of Rituximab in Refractory CIDP With or Without IgG4 Autoantibodies (RECIPE): Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593737223296","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Unclassified subtype of Guillain-Barré syndrome is associated with quick recovery"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137043398857344","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137044141501184","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Antibodies in sera from patients with inflammatory demyelinating polyradiculoneuropathy react with ganglioside LM1 and sulphatide of peripheral nerve myelin"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418519124733056","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Fine specificities of anti-LM1 IgG antibodies in Guillain-Barré syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994159394816","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981469869530240","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Anti‐LM1 antibodies in the sera of patients with Guillain‐Barré syndrome, Miller Fisher syndrome, and Motor Neuron Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981470940489216","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262944990432512","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Localization of GM1 and GD1b antigens in the human peripheral nervous system"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825894094155008","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895489199360","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"European Federation of Neurological Societies/Peripheral Nerve Society Guideline* on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society"}]},{"@id":"https://cir.nii.ac.jp/crid/1362825895929516544","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Guillain-Barré syndrome in northern China Relationship to <i>Campylobacter jejuni</i> infection and anti-glycolipid antibodies"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107368781095552","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107371386537344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Anti-ganglioside complex antibodies in Miller Fisher syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388843329536896","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"GM1/GalNAc-GD1a complex"}]},{"@id":"https://cir.nii.ac.jp/crid/1363388846355729280","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Assessment of current diagnostic criteria for Guillain-Barr� syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670318352082816","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ganglioside complexes as new target antigens in Guillain–Barré syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670320026356096","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.jneuroim.2011.08.016"},{"@type":"KAKEN","@value":"PRODUCT-12722545"},{"@type":"KAKEN","@value":"PRODUCT-13830556"},{"@type":"OPENAIRE","@value":"doi_dedup___::8204867b33d53801ffa02a14c8d4cc49"},{"@type":"CROSSREF","@value":"10.1016/j.jneuroim.2016.10.010_references_DOI_DWdOXnYvY3sxaPXnS3VhukaP5br"},{"@type":"CROSSREF","@value":"10.1016/j.jneuroim.2015.07.012_references_DOI_DWdOXnYvY3sxaPXnS3VhukaP5br"},{"@type":"CROSSREF","@value":"10.1016/j.jaut.2020.102571_references_DOI_DWdOXnYvY3sxaPXnS3VhukaP5br"},{"@type":"CROSSREF","@value":"10.1111/cen3.12452_references_DOI_DWdOXnYvY3sxaPXnS3VhukaP5br"},{"@type":"CROSSREF","@value":"10.1016/j.jns.2019.116509_references_DOI_DWdOXnYvY3sxaPXnS3VhukaP5br"},{"@type":"CROSSREF","@value":"10.1136/jnnp-2020-325053_references_DOI_DWdOXnYvY3sxaPXnS3VhukaP5br"},{"@type":"CROSSREF","@value":"10.2196/17117_references_DOI_DWdOXnYvY3sxaPXnS3VhukaP5br"},{"@type":"CROSSREF","@value":"10.1016/j.jocn.2021.07.025_references_DOI_DWdOXnYvY3sxaPXnS3VhukaP5br"},{"@type":"CROSSREF","@value":"10.1016/j.bbagen.2017.07.012_references_DOI_DWdOXnYvY3sxaPXnS3VhukaP5br"}]}